MobiHeal Logo

Protecting Clinical Trial Data: MDM Implementation for a Global Pharma Research Team

PharmaceuticalsClinical ResearchHIPAA ComplianceData Security
Case Study

Executive Summary

A global pharmaceutical firm conducting 100+ clinical trials secured 2,000+ mobile devices and achieved 100% HIPAA compliance using MobiHeal MDM. This led to a 90% reduction in breach risks and improved patient data security across 15 countries.

Client Overview

Industry: Pharmaceuticals (Clinical Research)

Key Challenges

  • 20+ annual PHI breaches due to insecure mobile device usage
  • Device diversity across iOS, Android, and legacy systems in 15 countries
  • $1.2M in potential HIPAA fines from audit failures and data mismanagement

Challenges

  • 1

    Sensitive Data Exposure

    Clinical data—including treatment outcomes and patient biomarkers—was sent via unencrypted channels, violating HIPAA and GDPR standards.

  • 2

    BYOD Risks

    Researchers used personal devices without encryption, allowing unauthorized access to sensitive patient records.

  • 3

    Regulatory Pressure

    HIPAA and GDPR compliance was hindered by manual audits and fragmented access control systems.

MobiHeal MDM Solution

End-to-End Encryption

  • Applied AES-256 encryption to all clinical trial data on devices and in transit.
  • Enabled VPN tunneling for secure remote access to global trial databases.

Containerized Work Profiles

  • Isolated EDC and clinical apps from personal content on BYOD devices.
  • Disabled screenshots and clipboard functions for protected apps.

Automated Compliance Reporting

  • Pre-configured HIPAA audit reports reduced preparation time by 90%.
  • Real-time compliance tracking for all mobile endpoints.

Remote Data Wipe

  • Instant remote erasure of PHI on lost/stolen devices.
  • Helped maintain zero data breach status post-MDM deployment.

Results

HIPAA Compliance Achieved

100%

Reduction in PHI Breach Risk

90%

Reduction in IT Management Hours

83%

Increase in Patient Data Encryption

60%

Before & After Metrics

MetricBefore MDMAfter MDMImprovement
PHI Breaches20/year0100% Reduction
HIPAA Audit Pass Rate65%100%35% Increase
IT Hours Spent on Device Management120/month20/month83% Reduction
Patient Data Encryption Rate40%100%60% Increase

Best Practices

  • Implement role-based access to ensure only approved researchers handle PHI.
  • Conduct quarterly penetration tests to identify weaknesses in mobile workflows.
  • Use biometric or MFA login methods to add layers of security for trial access.
  • Establish real-time audit trails to streamline HIPAA and GDPR readiness.
  • Deploy containerization to segment personal and corporate usage on all BYODs.

Industry Recognition

  • HIPAA Journal: "Encryption reduces clinical trial breaches by 95%"
  • Gartner: "70% of pharma firms will adopt MDM for clinical data by 2026"

Conclusion

MobiHeal MDM helped the global pharmaceutical team eliminate PHI breaches, reduce compliance risks, and streamline secure clinical operations across multiple geographies.

Ready to Secure Your Mobile Infrastructure?

Explore how MobiHeal MDM can protect your organization against evolving mobile threats.